GLI-M

Gliclazide and Metformin Tablet is a widely prescribed combination medicine for managing Type 2 diabetes mellitus in adults. It combines two effective anti-diabetic agents—Gliclazide, a sulfonylurea that stimulates insulin release from the pancreas, and Metformin, a biguanide that decreases glucose production in the liver and improves insulin sensitivity in the body. This dual-action formula helps lower fasting and post-meal blood glucose levels more effectively than monotherapy. By improving insulin function and reducing excess sugar production, the medicine helps maintain stable blood sugar levels and prevents complications such as neuropathy, nephropathy, retinopathy, heart disease, and stroke. Gliclazide and Metformin tablets are typically prescribed when diet, exercise, and single-drug therapy are not sufficient to control blood sugar. The dosage depends on the patient’s blood glucose levels, medical history, and physician recommendations. Regular monitoring of blood sugar is essential during treatment.